---  
layout: startup_page  
title: "IDRx"  
id: "idrx.com"  
permalink: "/idrxidrx.com08072024/"  
website: "https://www.idrx.com/"  
funding_round: "Series B"  
funding_amount: "$120M"  
investors: "RA Capital Management, Commodore Capital, Blackstone Multi-Asset Investing, Rock Springs Capital, a U.S.-based healthcare-focused fund, Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, Nextech Invest Ltd., Forge Life Science Partners, Nick Lydon, Merck KGaA"  
about: "IDRx, Inc. is a clinical-stage biopharmaceutical company focused on developing precision therapies for cancer treatment. Their lead product candidate, IDRX-42, is a potent KIT inhibitor targeting GIST, aiming to overcome treatment resistance and adverse events of existing therapies. The company is advancing IDRX-42 through clinical trials."  
markets: "Biotechnology, Oncology, Pharmaceuticals, Life Science, Product Research"  
hq: "Plymouth, Massachusetts, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/idrx/about"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/idrx"  
pitchbook: "https://pitchbook.com/profiles/company/503071-75"  

date_display: "07-Aug-2024"  
date: "2024-08-07"

# SEO Optimization  
meta_title: "IDRx - Series B Funding ($120M)"  
meta_description: "IDRx, IDRx, Inc. is a clinical-stage biopharmaceutical company focused on developing precision therapies for cancer treatment. Their lead product candidate,..."  
meta_keywords: "IDRx, Biotechnology, Oncology, Pharmaceuticals, Life Science, Product Research, Series B funding"  
canonical_url: "https://startup.projectstartups.com/idrxidrx.com08072024/"  
---